LIGAND PHARMACEUTICALS INC - 8-K Filing
Ligand Pharmaceuticals entered into Amendment No. 1 to its April 27, 2026 merger agreement with XOMA Royalty Corporation on May 16, 2026, adding XOMA Royalty Holdings Corporation as a party and facilitating the Holding Company Reorganization under Nevada law. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)
Tickers: $LGND